Utilizing a proinflammatory cocktail of TNF-α, IL-6, and IL-1β to mimic the inflammatory environment of inflammatory bowel disease (IBD), we observed clear differences in the cellular responses to acute versus chronic inflammation [11]. This evidence concerns the gene IL1B and inflammatory bowel disease.